Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT00179920
Eligibility Criteria:
Eligibility Criteria:
* Initial clinical diagnosis of Retinoblastoma, with Bilateral tumors, OR Unilateral tumor with hope for salvage of vision AND Multiple primary tumors, or positive family history for retinoblastoma, or age \< 12 months
* No prior antitumor therapy (except enucleation of one eye)
* At least one tumor exceeds 6 mm in diameter
* No evidence of dissemination outside the globe
* Signed IRB-approved informed consent
* Patient/family available for follow-up
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00179920
Study Brief:
Protocol Section:
NCT00179920